Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses.
OBJECTIVE
To determine the effectiveness of intravenous immunoglobulin administration to premature infants in the prevention and/or treatment of bacterial infection.


METHODS
Computer searches of MEDLINE, EMBASE, SCISEARCH and Oxford Database of Perinatal Trials were made. Two independent researchers applied inclusion criteria of: randomised controlled trial; premature and/or low birthweight infant; use of intravenous immunoglobulin; and infection or mortality. Nineteen of 44 identified studies fulfilled these criteria. Study quality was assessed and information on study population, intervention, and outcomes were collected.


RESULTS
Studies were divided into prophylaxis or treatment; results were tabulated for infection, sepsis, and death from all causes. For 17 studies of prophylaxis (n = 5245), the relative risk and confidence interval were, for proved infection 0.81, 0.67-0.97; for sepsis 0.87, 0.66-1.13; for death from all causes 0.85, 0.64-1.14. Some outcome results were heterogeneous. Two treatment studies showed no reduction in mortality when combined.


CONCLUSIONS
Routine administration of intravenous immunoglobulin to preterm infants is not recommended.
Lacy
J B
JB
Department of Newborn and Developmental Paediatrics, Women's College Hospital, Toronto, Canada.
Ohlsson
A
A
D001424:Bacterial Infections / Q000517:prevention & control* / Q000628:therapy; D016206:Databases, Bibliographic; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control* / Q000628:therapy
D016756:Immunoglobulins, Intravenous